Literature DB >> 26399206

Sex, drugs and prisons: HIV prevention strategies for over 190 000 clients in Ukraine.

O Denisiuk1, P Smyrnov1, A M V Kumar2, S Achanta3, K Boyko1, M Khogali4, B Naik3, R Zachariah4.   

Abstract

SETTING: One hundred and forty non-governmental organisations implementing human immunodeficiency virus (HIV) prevention programmes among clients, including people who inject drugs, prisoners, female sex workers, men who have sex with men and street children in Ukraine, 2010-2011.
OBJECTIVE: Among enrolled clients, to assess factors associated with HIV testing, HIV retesting within a year of initial testing and HIV seroconversion.
DESIGN: Retrospective cohort study involving record reviews.
RESULTS: Of 192 487 clients, 42 109 (22%) underwent an initial HIV test (22% were positive). Among HIV-negative clients at baseline, 10 858 (27%) were retested within a year: 317 (3%) of these were HIV-positive. HIV testing and retesting rates were lower among prisoners (0.3%) and others (street children and partners of those in risk groups, 6%), and those who did not receive counselling or services such as condom and needle distribution. Individuals who were not counselled were more likely to seroconvert.
CONCLUSIONS: In this large cohort of high-risk groups from Eastern Europe, HIV testing was low and HIV sero-conversion was high. This is of public health concern, bringing into question the overall quality of counselling and how well it is tailored to the specific needs of various risk groups. Qualitative studies to understand the reasons for non-testing are urgently required for designing client-specific interventions.

Entities:  

Keywords:  HIV prevention; HIV seroconversion; HIV testing; injection drug users; most-at-risk populations

Year:  2014        PMID: 26399206      PMCID: PMC4539029          DOI: 10.5588/pha.13.0110

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  1 in total

1.  Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation.

Authors:  S R Friedman; B J Kottiri; A Neaigus; R Curtis; S H Vermund; D C Des Jarlais
Journal:  Am J Epidemiol       Date:  2000-11-15       Impact factor: 4.897

  1 in total
  5 in total

1.  Challenges in expanding access to antiretroviral therapy for key affected populations.

Authors:  Adeeba Kamarulzaman
Journal:  Public Health Action       Date:  2014-06-21

2.  Does research through Structured Operational Research and Training (SORT IT) courses impact policy and practice?

Authors:  A M V Kumar; H D Shewade; J P Tripathy; N Guillerm; K Tayler-Smith; S Dar Berger; K Bissell; A J Reid; R Zachariah; A D Harries
Journal:  Public Health Action       Date:  2016-01-04

3.  Divergent estimates of HIV incidence among people who inject drugs in Ukraine.

Authors:  Olga Morozova; Robert E Booth; Sergii Dvoriak; Kostyantyn Dumchev; Yana Sazonova; Tetiana Saliuk; Forrest W Crawford
Journal:  Int J Drug Policy       Date:  2019-08-10

4.  Patterns of harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine: A two-part latent profile analysis.

Authors:  Danielle C Ompad; Jiayu Wang; Konstantin Dumchev; Julia Barska; Maria Samko; Oleksandr Zeziulin; Tetiana Saliuk; Olga Varetska; Jack DeHovitz
Journal:  Int J Drug Policy       Date:  2017-02-01

5.  Locally adaptive Bayesian birth-death model successfully detects slow and rapid rate shifts.

Authors:  Andrew F Magee; Sebastian Höhna; Tetyana I Vasylyeva; Adam D Leaché; Vladimir N Minin
Journal:  PLoS Comput Biol       Date:  2020-10-28       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.